Emicizumab-kxwh Subcutaneous and Mogamulizumab-kpkc Intravenous
Determining the interaction of Emicizumab-kxwh Subcutaneous and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Molindone
- Emicizumab-kxwh Subcutaneous-Mometasone (Oral Inhalation)
- Emicizumab-kxwh Subcutaneous-Mometasone and Formoterol
- Emicizumab-kxwh Subcutaneous-Mometasone and formoterol Inhalation
- Emicizumab-kxwh Subcutaneous-Mometasone Cream
- Emicizumab-kxwh Subcutaneous-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Emla
- Mogamulizumab-kpkc Intravenous-Emla Topical
- Mogamulizumab-kpkc Intravenous-Emo-Cort Scalp Solution Topical application
- Mogamulizumab-kpkc Intravenous-Emo-Cort Topical application
- Mogamulizumab-kpkc Intravenous-Emoquette
- Mogamulizumab-kpkc Intravenous-Empagliflozin